Skip to main content
Erschienen in: Clinical Autonomic Research 2/2022

07.03.2022 | Letter to the Editor

Quality of life and injury due to vasovagal syncope

verfasst von: Juliana Jorge, Satish Raj, Zhiying Liang, Robert Sheldon

Erschienen in: Clinical Autonomic Research | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Excerpt

Vasovagal syncope (VVS) is the most common type of syncope, occurring in more than 35% of people by age 60 [ 1]. Although not life-threatening [ 2], the potential for injury is worrisome. At least 33% of patients report bruises, lacerations, and more serious trauma due to a syncopal spell [ 3, 4], and about 15% of fainting is associated with trauma [ 3]. VVS patients also have anxiety, depression, and reduced health-related quality of life (HRQoL) [ 5]. Despite evidence that VVS patients’ perception of HRQoL seemed to improve after enrolling in a clinical trial, even with recurrent fainting [ 6], it remains unclear whether patients who sustained an injury have a lower HRQoL or blunted improvement in HRQoL compared to those who fainted without an injury. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, Van Dijk N (2006) Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol 17(11):1172–1176 CrossRefPubMed Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, Van Dijk N (2006) Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol 17(11):1172–1176 CrossRefPubMed
2.
Zurück zum Zitat Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ et al (2002) Incidence and prognosis of syncope. N Engl J Med 347(12):878–885 CrossRefPubMed Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ et al (2002) Incidence and prognosis of syncope. N Engl J Med 347(12):878–885 CrossRefPubMed
3.
Zurück zum Zitat Jorge JG, Pournazari P, Raj SR, Maxey C, Sheldon RS (2020) Frequency of injuries associated with syncope in the prevention of syncope trials. Europace 22(12):1896–1903 CrossRefPubMedPubMedCentral Jorge JG, Pournazari P, Raj SR, Maxey C, Sheldon RS (2020) Frequency of injuries associated with syncope in the prevention of syncope trials. Europace 22(12):1896–1903 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Jorge JG, Raj SR, Teixeira PS, Teixeira JAC, Sheldon RS (2021) Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. Europace 23:1092–1099 CrossRefPubMed Jorge JG, Raj SR, Teixeira PS, Teixeira JAC, Sheldon RS (2021) Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. Europace 23:1092–1099 CrossRefPubMed
5.
Zurück zum Zitat Ng J, Sheldon RS, Ritchie D, Raj V, Raj SR (2019) Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals. Pacing Clin Electrophysiol 42(2):180–188 PubMed Ng J, Sheldon RS, Ritchie D, Raj V, Raj SR (2019) Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals. Pacing Clin Electrophysiol 42(2):180–188 PubMed
6.
Zurück zum Zitat Ng J, Sheldon RS, Maxey C, Ritchie D, Raj V, Exner DV et al (2019) Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up. Auton Neurosci Basic Clin. 219:42–48 CrossRef Ng J, Sheldon RS, Maxey C, Ritchie D, Raj V, Exner DV et al (2019) Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up. Auton Neurosci Basic Clin. 219:42–48 CrossRef
7.
Zurück zum Zitat Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C et al (2006) Prevention of Syncope Trial (POST): a Randomized, Placebo-Controlled Study of Metoprolol in the Prevention of Vasovagal Syncope. Circulation 113(9):1164–1170 CrossRefPubMed Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C et al (2006) Prevention of Syncope Trial (POST): a Randomized, Placebo-Controlled Study of Metoprolol in the Prevention of Vasovagal Syncope. Circulation 113(9):1164–1170 CrossRefPubMed
8.
Zurück zum Zitat Sheldon R, Raj SR, Rose MS, Morillo CA, Krahn AD, Medina E et al (2016) Fludrocortisone for the prevention of vasovagal syncope: a Randomized Placebo-Controlled Trial. J Am Coll Cardiol 68(1):1–9 CrossRefPubMed Sheldon R, Raj SR, Rose MS, Morillo CA, Krahn AD, Medina E et al (2016) Fludrocortisone for the prevention of vasovagal syncope: a Randomized Placebo-Controlled Trial. J Am Coll Cardiol 68(1):1–9 CrossRefPubMed
10.
Zurück zum Zitat Hays RD, Sherbourne CD, Mazel RM (1993) The Rand 36-item health survey 1.0. Health Econ 2:217–227 CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM (1993) The Rand 36-item health survey 1.0. Health Econ 2:217–227 CrossRefPubMed
11.
Metadaten
Titel
Quality of life and injury due to vasovagal syncope
verfasst von
Juliana Jorge
Satish Raj
Zhiying Liang
Robert Sheldon
Publikationsdatum
07.03.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 2/2022
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-022-00856-3

Weitere Artikel der Ausgabe 2/2022

Clinical Autonomic Research 2/2022 Zur Ausgabe